In a surprising turn, President Trump has retracted his plans for exorbitant tariffs on pharmaceuticals and semiconductors from the EU, capping them at 15%. This agreement, reached after intense negotiations, aims to stabilize trade relations and reduce costs for consumers and businesses.
Discover the key elements of President Trump's new trade deal with the EU, including significant changes to tariffs on cars, pharmaceuticals, and more. Find out how this will affect trade relations and investments!
The White House unveils a $550 billion investment agreement with Japan, promising strategic investments in key sectors. But experts raise doubts about its feasibility amidst ongoing tariff controversies.
As Trump meets EU leaders in Scotland, intense negotiations are underway to prevent a costly trade war. With key issues at stake and heavy security, will a new trade deal emerge?
In a surprising turn, Anne Wojcicki's nonprofit, TTAM Research Institute, has acquired 23andMe for $305 million after its bankruptcy. This acquisition addresses concerns about genetic data privacy while aiming to uphold the company's mission.
Anne Wojcicki's nonprofit has won the bid to buy 23andMe, raising critical questions about the future of genetic data privacy. Experts warn that sensitive DNA information could be at risk.
In a groundbreaking move, 27 states and D.C. have filed a lawsuit to prevent 23andMe from selling customer genetic data without consent. This legal battle raises significant privacy concerns for users.
Hims & Hers Health is set to acquire European telehealth platform Zava, aiming to expand its services across Europe. The deal promises to add 1.3 million customers and enhance access to affordable medications in Ireland, France, and Germany.
In a bold move, President Trump is set to sign an executive order mandating the U.S. health department to negotiate lower drug prices with pharmaceutical companies. This could drastically change healthcare costs for millions of Americans.
In a surprising move, China has exempted some U.S. imports from steep tariffs, hinting that the trade war may be easing. However, Beijing contradicts claims of ongoing negotiations with Washington.
